OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
October 02, 2022
FDA backs joint reviews, common research policies, and modern production methods around the world.
ROSS Ribbon Blenders are a customizable solution designed to minimize risk and maximize productivity.
The new inorganic pyrophosphate from Canvax is intended for use in RNA IVT reactions.
L.B. Bohle’s QbCon 1 is intended to meet all quality requirements for long granulation processing time.
Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.
September 30, 2022
Forge Biologics will offer three grades of plasmid manufacturing services at its Columbus, Ohio, location.
PerkinElmer has unveiled a cell analysis solution to streamline cell and gene therapy research and manufacturing.
September 28, 2022
The dedicated solid-state research and development suite is designed to promote discovery of novel polymorph, salt, and cocrystal forms.
September 21, 2022
Lonza has expanded its HPAPI multipurpose suite for payload-linker manufacturing.
Boehringer Ingelheim will use Virtuosi to train employees at three aseptic sites across its network.